What is the current market price of Entrectinib and the best price per box?

Entrectinib is a targeted drug used to treat tumors carrying NTRK gene fusion and ROS1-positive non-small cell lung cancer. At present, entrectinib has been officially launched in China and has been included in the national medical insurance directory, which allows patients to purchase it at regular domestic medical institutions and pharmacies. Medical insurance coverage has greatly reduced patients’ financial pressure and improved the accessibility of medicines.

In the domestic market, the price of entrectinib is about 20,000 yuan per box. Specific prices will fluctuate according to different regions and hospitals, and medical insurance reimbursement ratios and policies also vary. Patients should consult local hospital pharmacies for detailed price information and medical insurance reimbursement policies before purchasing medicines in order to reasonably arrange treatment costs and ensure the continuity and effectiveness of medication.

Compared with the domestic original drug, there are generic versions of entrectinib on the foreign market, which are more affordable. In particular, the price of generic drugs produced in Laos, with the specification of 100mg*60 tablets, is only about more than one thousand yuan. These generic drugs are basically the same as the original drugs in terms of ingredients and efficacy, providing patients with an affordable alternative, especially for price-sensitive patient groups.

Overall, the domestic listing of entrectinib and its inclusion in medical insurance provide patients with protection through official channels, ensuring drug quality and after-sales service. Generic drugs bring lower economic barriers to patients. Patients should combine their own actual conditions, follow the doctor's advice, and choose an appropriate medication plan to ensure treatment effect and medication safety.

Reference materials:https://www.drugs.com